Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: Czechia Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20052
20061
20073
20082
20093
20104
20114
20121
20131
20141
20152
20162
20173
20181
20191
20202
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
Boehringer Ingelheim4
GlaxoSmithKline4
Novo Nordisk A/S4
Amgen3
AstraZeneca2
Sanofi2
ActivX Biosciences, Inc.1
Akros Pharma Inc.1
Aptabio Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 238
Diabetes Mellitus8
Diabetic Nephropathies4
Renal Insufficiency, Chronic4
Albuminuria2
Heart Failure2
Hyperglycemia2
Obesity2
Diabetes Mellitus, Lipoatrophic1
Diabetes Mellitus, Type 11

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.